Rock Springs Capital Management LP Allogene Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$32.38 - $44.96 $14.3 Million - $19.8 Million
-440,468 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$18.39 - $54.04 $3.5 Million - $10.3 Million
190,468 Added 76.19%
440,468 $18.9 Million
Q1 2020

May 15, 2020
BUY
$18.22 - $28.25 $4.56 Million - $7.06 Million
250,000 New
250,000 $4.86 Million

Others Institutions Holding ALLO

# of Institutions
165
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $265M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email